Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.40 |
| ▸ | QPCT | Q16769 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | CYP17A1 | P05093 | 3/20 | 0.32 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.30 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27003116 | 0.80 | QPCT (0.40) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL918948 | 0.78 | NFKB1 (0.39) | NFKB1QPCTHSD17B10QPCTLCYP19A1 | |
| SCHEMBL10503985 | 0.70 | NFKB1 (0.46) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL217284 | 0.70 | — | — | |
| SCHEMBL12020402 | 0.69 | NFKB1 (0.43) | NFKB1QPCTHSD17B10QPCTLHTT | |
| Bromide SCHEMBL28508208 | 0.69 | NFKB1 (0.43) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL23302369 | 0.65 | NFKB1 (0.40) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL1953406 | 0.65 | NFKB1 (0.40) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL538362 | 0.65 | NFKB1 (0.40) | NFKB1QPCTHSD17B10QPCTLHTT | |
| SCHEMBL40476 | 0.63 | NFKB1 (0.39) | NFKB1QPCTHSD17B10QPCTLCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2841401-B1 | METHOD FOR PROTECTING HYDROXYL, AMINE OR THIOL FUNCTIONAL GROUPS WITH TETRAISOPROPYLDISILANE AND THE CORRESPONDING PROTECTED COMPOUNDS | INST CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) | 2018-07-04 | — | — | EP | disclosed |
| US-9290521-B2 | Method for protecting hydroxyl or amine or thiol functions, novel compounds with protected hydroxyl or amine or thiol groups, as well novel compounds for the implementation of this method | INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) | 2016-03-22 | — | — | US | disclosed |
| US-20150094462-A1 | METHOD FOR PROTECTING HYDROXYL OR AMINE OR THIOL FUNCTIONS, NOVEL COMPOUNDS WITH PROTECTED HYDROXYL OR AMINE OR THIOL GROUPS, AS WELL NOVEL COMPOUNDS FOR THE IMPLEMENTATION OF THIS METHOD | FUNDACJA UNIWERSYTETU IM. ADAMA MICKIEWICZA W POZNANIU (PL) | 2015-04-02 | — | — | US | disclosed |
| EP-2841401-A1 | METHOD FOR PROTECTING HYDROXYL, AMINE OR THIOL FUNCTIONAL GROUPS WITH TETRAISOPROPYDISILANE AND THE CORRESPONDING PROTECTED COMPOUNDS | Instytut Chemii Bioorganicznej Polskiej Akademii Nauk (PL) | 2015-03-04 | — | — | EP | disclosed |
| WO-2013165266-A1 | METHOD FOR PROTECTING HYDROXYL, AMINE OR THIOL FUNCTIONAL GROUPS WITH TETRAISOPROPYDISILANE AND THE CORRESPONDING PROTECTED COMPOUNDS | INSTYTUT CHEMII BIOORGANICZNEJ POLSKIEJ AKADEMII NAUK (PL) | 2013-11-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150094462-A1 | METHOD FOR PROTECTING HYDROXYL OR AMINE OR THIOL FUNCTIONS, NOVEL COMPOUNDS WITH PROTECTED HYDROXYL OR AMINE OR THIOL GROUPS, AS WELL NOVEL COMPOUNDS FOR THE IMPLEMENTATION OF THIS METHOD | DUS2, TXN, OGG1 | NFKB1 3704/4885QPCT 1044/4885HSD17B10 1635/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.